FBRX Forte Biosciences, Inc. - Common Stock

NASDAQ · Biotechnology · View on SEC EDGAR ↗
$76.93
Price · Aug 19, 2026
Fundamentals as of Aug 12, 2026

FBRX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$76.93
Market Cap
$996M
P/E (TTM)
-16.3
EPS (TTM)
$-4.71
Revenue (TTM)
Div Yield
ROE
-86.9%
Debt/Equity
52W Range
$10 – $77

FBRX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income
4-point trend, -26.5%
2016-12-31 2019-12-31
EPS $-4.71
5-point trend, -203.9%
2021-12-31 2025-12-31
Free Cash Flow $-51M
4-point trend, -60.4%
2017-12-31 2025-12-31
Margins -2555.2%

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
FBRX
Peer Median
P/E (TTM)
5-point trend, +83.2%
-16.3
P/S (TTM)
5-point trend, -99.5%
55.2
22.4
P/B
5-point trend, -99.5%
16.3
2.7
Price / FCF
4-point trend, +99.7%
-19.5

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
FBRX
Peer Median
Operating Margin
3-point trend, -923.7%
-2602.5%
Net Profit Margin
3-point trend, -841.4%
-2555.2%
-638.9%
ROA
5-point trend, -91.6%
-96.1%
-43.1%
ROE
5-point trend, +6.1%
-86.9%
-49.0%
ROIC
2-point trend, -108.8%
-117.6%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
FBRX
Peer Median
Current Ratio
5-point trend, -34.3%
3.9
9.0
Quick Ratio
5-point trend, +50.2%
3.7

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
FBRX
Peer Median
Revenue YoY
4-point trend, -26.5%
106.6%
Revenue CAGR 3Y
4-point trend, -26.5%
155.9%

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
FBRX
Peer Median
EPS (Diluted)
5-point trend, -203.9%
$-4.71

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
FBRX
Peer Median

FBRX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 11 analysts
  • Strong Buy 2 18.2%
  • Buy 4 36.4%
  • Hold 5 45.5%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

5 analysts · 2026-08-13
Median target $77.00 +0.1%
Mean target $73.80 -4.1%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
0.07%
Period EPS Actual EPS Est Surprise
June 30, 2026 $-0.97 $-0.90 -0.07%
March 31, 2026 $-1.24 $-1.22 -0.02%
Dec. 31, 2025 $-1.39 $-1.24 -0.15%
Sept. 30, 2025 $-0.99 $-1.09 0.10%
June 30, 2025 $-0.96 $-1.13 0.17%
March 31, 2025 $-1.37 $-0.97 -0.40%
Dec. 31, 2024 $-2.45 $-3.34 0.89%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
FBRX $353M -5.8 106.6% -2555.2% -86.9%
ANAB -105.4 157.0%
NTLA $1.05B -2.4 16.9% -609.8% -59.5%
RXRX $2.16B -2.8 26.9% -863.4% -62.9%
ZYME $1.97B -24.4 38.9% -76.6% -26.9%
BCAX $953M -6.7 -33.0%
XNCR $1.10B -12.3 13.7% -73.2% -14.0%
TRAX
ABSI $529M -4.2 -38.2% -4113.7% -63.5%
TYRA $1.41B -13.1 -42.7%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 14
Annual Income Statement data for FBRX
Metric Trend 2025202420232022202120202019201820172016
Revenue 4-point trend, -26.5% · · · · · · $36.0K $18M $41.0K $49.0K
R&D Expense 4-point trend, +66.4% · · · · · · $45M $51M $29M $27M
SG&A Expense 10-point trend, +174.5% $12M $15M $11M $8M $8M $4M $1M $13M $9M $5M
Operating Expenses 10-point trend, +122.6% $71M $37M $32M $14M $21M $46M $4M $64M $38M $32M
Operating Income 10-point trend, -123.0% $-71M $-37M $-32M $-14M $-21M $-46M $-4M $-46M $-38M $-32M
Other Non-op 9-point trend, +77.8% $-396.0K $-190.0K $-114.0K $-145.0K $-222.0K $-205.0K $-5.0K · $-1M $-2M
Pretax Income 7-point trend, -104.1% $-68M $-35M $-31M · · · $-64M $-47M $-39M $-33M
Income Tax 6-point trend, +103600.0% $1M $0 · · · · $1.0K $2M $1.0K $1.0K
Net Income 10-point trend, -107.2% $-69M $-35M $-31M $-14M $-22M $-46M $-4M $-49M $-39M $-33M
EPS (Basic) 5-point trend, -203.9% $-4.71 $-12.17 $-24.92 $-0.80 $-1.55 · · · · ·
EPS (Diluted) 5-point trend, -203.9% $-4.71 $-12.17 $-24.92 $-0.80 $-1.55 · · · · ·
Shares (Basic) 2-point trend, +24.5% · · · 17,383,531 13,967,818 · · · · ·
Shares (Diluted) 2-point trend, +24.5% · · · 17,383,531 13,967,818 · · · · ·
EBITDA 6-point trend, -87.8% $-71M $-37M · · $-21M $-46M · $-46M $-38M ·
Balance Sheet 23
Annual Balance Sheet data for FBRX
Metric Trend 2025202420232022202120202019201820172016
Cash & Equivalents 10-point trend, +1296.7% $77M $22M $37M $41M $42M $59M $7M $41M $36M $6M
Short-term Investments 2-point trend, -100.0% $0 $36M · · · · · · · ·
Prepaid Expense 10-point trend, +198.7% $4M $3M $1M $411.0K $476.0K $1M $567.0K $2M $2M $1M
Current Assets 10-point trend, +148.3% $81M $61M $38M $42M $43M $60M $8M $98M $91M $32M
PP&E (Net) 8-point trend, -82.6% $129.0K $77.0K $109.0K · · $97.0K $152.0K $4M $1M $743.0K
PP&E (Gross) 7-point trend, -92.4% $241.0K $125.0K $118.0K · · · $3M $7M $4M $3M
Accum. Depreciation 7-point trend, -95.4% $112.0K $48.0K $9.0K · · · $2M $3M $3M $2M
Other Non-current Assets 10-point trend, -4.0% $2M $138.0K $544.0K $486.0K $786.0K $1M $0 $1M $227.0K $2M
Total Assets 10-point trend, +134.2% $83M $62M $39M $42M $43M $61M $8M $103M $92M $35M
Accounts Payable 10-point trend, +499.6% $10M $5M $1M $1M $946.0K $1M $2M $3M $2M $2M
Accrued Liabilities 10-point trend, +97.9% $11M $4M $2M $2M $812.0K $1M $343.0K $13M $8M $5M
Short-term Debt 3-point trend, -34.1% · · · · · · $5M · $7M $7M
Current Liabilities 10-point trend, +44.3% $21M $9M $4M $3M $2M $2M $2M $17M $17M $14M
Capital Leases · · · · · · $4M · · ·
Other Non-current Liabilities 2-point trend, +1180.2% $1M · · · · · $81.0K · · ·
Total Liabilities 6-point trend, -23.2% $22M $9M · · · · $17M $45M $21M $28M
Total Debt 2-point trend, +142.0% · · · · · · · $26M $11M ·
Common Stock 10-point trend, +550.0% $13.0K $6.0K $1.0K $21.0K $15.0K $13.0K $2.0K $23.0K $20.0K $2.0K
Retained Earnings 10-point trend, -74.5% $-223M $-154M $-119M $-87M $-73M $-51M $-5M $-216M $-167M $-128M
AOCI 6-point trend, +108.8% $3.0K $11.0K $4.0K · · · $10.0K $-23.0K $-34.0K ·
Stockholders' Equity 10-point trend, +149.0% $61M $52M $35M $39M $42M $59M $-5M $-736.0K $71M $-124M
Liabilities + Equity 10-point trend, +134.2% $83M $62M $39M $42M $43M $61M $8M $103M $92M $35M
Shares Outstanding 10-point trend, +487.9% 12,948,308 6,393,323 1,453,402 21,000,069 14,754,447 12,830,598 2,108,266 23,000,151 19,882,551 2,202,517
Cash Flow 10
Annual Cash Flow data for FBRX
Metric Trend 2025202420232022202120202019201820172016
Stock-based Comp 10-point trend, +373.0% $6M $3M $3M $4M $4M $956.0K $36.0K $7M $4M $1M
Deferred Tax Flat — no change across 9 periods $0 $0 $0 $0 $0 $0 $0 · $0 $0
Operating Cash Flow 10-point trend, -72.3% $-51M $-31M $-29M $-8M $-17M $-18M $-3M $-34M $-31M $-30M
CapEx 7-point trend, -77.9% $116.0K $37.0K $88.0K · · · $162.0K $2M $655.0K $525.0K
Investing Cash Flow 8-point trend, +47.5% $36M $-36M $47.0K · · $4M $-162.0K $-4M $-28M $25M
Stock Issued 8-point trend, +17690.0% $2M $0 · $7M · $67M $551.0K $661.0K $507.0K $10.0K
Net Stock Activity 4-point trend, +250.9% $2M · · · · $67M · $661.0K $507.0K ·
Financing Cash Flow 10-point trend, +2874.3% $69M $52M $25M $7M $-44.0K $67M $5M $44M $89M $2M
Net Change in Cash 10-point trend, +2172.5% $55M $-15M $-4M $-944.0K $-17M $52M $2M $5M $30M $-3M
Free Cash Flow 4-point trend, -60.4% $-51M $-31M · · · · · $-36M $-32M ·
Profitability 7
Annual Profitability data for FBRX
Metric Trend 2025202420232022202120202019201820172016
Operating Margin 3-point trend, -923.7% -2602.5% -2785.5% · · · · · -254.2% · ·
Net Margin 3-point trend, -841.4% -2555.2% -2700.0% · · · · · -271.4% · ·
Pretax Margin 3-point trend, -860.7% -2517.1% -2700.0% · · · · · -262.0% · ·
EBITDA Margin 3-point trend, -923.7% -2602.5% -2785.5% · · · · · -254.2% · ·
ROA 6-point trend, -57.3% -96.1% -70.6% · · -41.5% -134.9% · -50.2% -61.1% ·
ROE 6-point trend, -159.5% -86.9% -114.7% · · -51.0% -117.2% · -92.5% 146.0% ·
ROIC 2-point trend, -108.8% -117.6% · · · · · · -56.3% · ·
Liquidity & Solvency 4
Annual Liquidity & Solvency data for FBRX
Metric Trend 2025202420232022202120202019201820172016
Current Ratio 6-point trend, -25.7% 3.9 6.8 · · 24.2 26.5 · 5.9 5.2 ·
Quick Ratio 6-point trend, +78.9% 3.7 6.4 · · 23.9 26.0 · 2.5 2.1 ·
Debt / Equity 2-point trend, +195.9% · · · · · · · 0.5 0.2 ·
LT Debt / Equity 2-point trend, +783.5% · · · · · · · 0.5 0.1 ·
Efficiency 1
Annual Efficiency data for FBRX
Metric Trend 2025202420232022202120202019201820172016
Asset Turnover 3-point trend, -79.7% 0.0 0.0 · · · · · 0.2 · ·
Per Share 3
Annual Per Share data for FBRX
Metric Trend 2025202420232022202120202019201820172016
Book Value / Share 6-point trend, +31.8% $4.71 $8.21 · · $2.82 $4.60 · $2.53 $3.58 ·
Cash / Share 6-point trend, +228.9% $5.94 $3.48 · · $2.85 $4.58 · $1.77 $1.81 ·
EPS (TTM) 5-point trend, -203.9% $-4.71 $-12.17 $-24.92 $-0.80 $-1.55 · · · · ·
Growth Rates 2
Annual Growth Rates data for FBRX
Metric Trend 2025202420232022202120202019201820172016
Revenue YoY 3-point trend, -82.0% 106.6% 16.9% 593.8% · · · · · · ·
Revenue CAGR 3Y 155.9% · · · · · · · · ·
Valuation (TTM) 14
Annual Valuation (TTM) data for FBRX
Metric Trend 2025202420232022202120202019201820172016
Revenue TTM 9-point trend, +43890.2% $18M $18M $18M $18M $18M $18M $36.0K $18M $41.0K ·
Net Income TTM 9-point trend, -78.2% $-69M $-35M $-31M $-14M $-22M $-46M $-4M $-49M $-39M ·
Market Cap 6-point trend, -99.5% $353M $145M · · $789M $11.68B · $70.81B $76.42B ·
Enterprise Value 2-point trend, -7.3% · · · · · · · $70.80B $76.40B ·
P/E 5-point trend, +83.2% -5.8 -1.9 -0.8 -31.2 -34.5 · · · · ·
P/S 6-point trend, -100.0% 19.6 8.1 · · 43.8 647.5 · 3926.1 1863989.2 ·
P/B 6-point trend, -99.5% 5.8 2.8 · · 19.0 198.0 · 1217.8 1075.1 ·
P / Tangible Book 6-point trend, -97.1% 5.8 2.8 21.1 13.5 19.0 198.0 · · · ·
P / Cash Flow 6-point trend, +99.7% -6.9 -4.7 · · -47.3 -633.9 · -2054.4 -2454.7 ·
P / FCF 4-point trend, +99.7% -6.9 -4.7 · · · · · -1943.4 -2404.2 ·
EV / EBITDA 2-point trend, +24.0% · · · · · · · -1544.0 -2030.3 ·
EV / FCF 2-point trend, +19.2% · · · · · · · -1943.0 -2403.4 ·
EV / Revenue 2-point trend, -99.8% · · · · · · · 3925.3 1863376.8 ·
Earnings Yield 5-point trend, -495.5% -17.3% -53.6% -121.3% -3.2% -2.9% · · · · ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-312023-12-312022-12-312021-12-31
Operating Margin % -2602.5%-2785.5%
Net Income $-69M$-35M$-31M$-14M$-22M
Diluted EPS $-4.71$-12.17$-24.92$-0.80$-1.55
Balance Sheet
2025-12-312024-12-312023-12-312022-12-312021-12-31
Current Ratio 3.96.824.2
Quick Ratio 3.76.423.9
Cash Flow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Free Cash Flow $-51M$-31M

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 91 filers · $409.8M total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
34 (+15 vs prior Q) 13 (+6 vs prior Q) 30 (+13 vs prior Q) 16 (-4 vs prior Q) +5.5M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
FEDERATED HERMES, INC. $44,848,465 2,110,516 10.94% Shares
ORBIMED ADVISORS LLC $33,526,231 1,577,705 8.18% Shares
JANUS HENDERSON GROUP PLC $30,812,336 1,188,060 7.52% Shares
FRED ALGER MANAGEMENT, LLC $30,593,561 1,439,697 7.47% Shares
Affinity Asset Advisors, LLC $24,339,559 1,145,391 5.94% Shares
MPM BIOIMPACT LLC $20,983,270 987,448 5.12% Shares
TCG Crossover Management, LLC $19,550,000 920,000 4.77% Shares
VANGUARD CAPITAL MANAGEMENT LLC $18,311,911 861,737 4.47% Shares
Woodline Partners LP $15,146,001 712,753 3.70% Shares
ADAGE CAPITAL PARTNERS GP, L.L.C. $14,875,000 700,000 3.63% Shares
Integral Health Asset Management, LLC $14,343,750 675,000 3.50% Shares
MILLENNIUM MANAGEMENT LLC $13,922,979 655,199 3.40% Shares
TYBOURNE CAPITAL MANAGEMENT (HK) LTD $11,799,705 786,647 2.88% Shares
CITADEL ADVISORS LLC $11,388,789 535,943 2.78% Shares
FMR LLC $10,685,053 502,826 2.61% Shares
AMERIPRISE FINANCIAL INC $8,898,586 418,757 2.17% Shares
GEODE CAPITAL MANAGEMENT, LLC $8,502,392 400,003 2.07% Shares
Cable Car Capital, LP $8,500,000 400,000 2.07% Shares
STATE STREET CORP $6,981,093 328,522 1.70% Shares
Candriam S.C.A. $6,434,678 303,100 1.57% Shares
Boxer Capital Management, LLC $5,833,125 274,500 1.42% Shares
Trails Edge Capital Partners, LP $5,805,097 273,181 1.42% Shares
SPHERA FUNDS MANAGEMENT LTD. $5,305,976 249,693 1.29% Shares
Squadron Capital Management LLC $4,781,250 225,000 1.17% Shares
AWM Investment Company, Inc. $4,728,125 222,500 1.15% Shares
UBS Group AG $3,463,198 162,974 0.85% Shares
VANGUARD FIDUCIARY TRUST CO $2,893,698 136,174 0.71% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $2,842,634 133,771 0.69% Shares
Nuveen, LLC $2,302,374 108,347 0.56% Shares
VANGUARD GROUP INC $1,842,770 67,575 0.45% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $1,797,750 84,600 0.44% Put option
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $999,664 47,043 0.24% Shares
J. Goldman & Co LP $981,368 46,182 0.24% Shares
Balyasny Asset Management L.P. $826,583 38,898 0.20% Shares
MANGROVE PARTNERS IM, LLC $708,603 33,346 0.17% Shares
ENVESTNET ASSET MANAGEMENT INC $639,795 30,108 0.16% Shares
XTX Topco Ltd $636,374 29,947 0.16% Shares
WELLINGTON MANAGEMENT GROUP LLP $559,470 26,328 0.14% Shares
Trexquant Investment LP $534,820 25,168 0.13% Shares
Weil Company, Inc. $526,256 24,765 0.13% Shares
AlphaQuest LLC $512,785 18,804 0.13% Shares
RHUMBLINE ADVISERS $470,662 22,149 0.11% Shares
Ikarian Capital, LLC $445,655 20,972 0.11% Shares
JANE STREET GROUP, LLC $418,370 19,688 0.10% Shares
Persistent Asset Partners Ltd $388,089 18,263 0.09% Shares
WELLS FARGO & COMPANY/MN $375,360 17,664 0.09% Shares
Russell Investments Group, Ltd. $349,180 16,432 0.09% Shares
BNP PARIBAS FINANCIAL MARKETS $346,162 16,290 0.08% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $304,109 14,311 0.07% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $293,250 13,800 0.07% Call option
TWO SIGMA INVESTMENTS, LP $284,984 13,411 0.07% Shares
Squarepoint Ops LLC $261,736 12,317 0.06% Shares
BANK OF AMERICA CORP /DE/ $251,345 11,828 0.06% Shares
MetLife Investment Management, LLC $243,759 11,471 0.06% Shares
Bank of New York Mellon Corp $237,958 11,198 0.06% Shares
GOLDMAN SACHS GROUP INC $236,576 11,133 0.06% Shares
BlackRock, Inc. $218,153 10,266 0.05% Shares
ExodusPoint Capital Management, LP $217,239 10,223 0.05% Shares
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. $188,700 8,880 0.05% Shares
China Universal Asset Management Co., Ltd. $170,000 8,000 0.04% Shares
CITIGROUP INC $169,660 7,984 0.04% Shares
Invesco Ltd. $164,114 7,723 0.04% Shares
NEW YORK STATE COMMON RETIREMENT FUND $144,500 6,800 0.04% Shares
Vanguard Global Advisers, LLC $142,418 6,702 0.03% Shares
Police & Firemen's Retirement System of New Jersey $121,380 5,712 0.03% Shares
NORTHERN TRUST CORP $64,558 3,038 0.02% Shares
BARCLAYS PLC $58,438 2,750 0.01% Shares
Tower Research Capital LLC (TRC) $45,475 2,140 0.01% Shares
Legal & General Group Plc $39,950 1,880 0.01% Shares
Ameritas Investment Partners, Inc. $37,358 1,758 0.01% Shares
STRS OHIO $36,125 1,700 0.01% Shares
Quantbot Technologies LP $30,685 1,444 0.01% Shares
State of Wyoming $21,675 1,020 0.01% Shares
ROYAL BANK OF CANADA $16,000 748 0.00% Shares
NATIONAL BANK OF CANADA /FI/ $12,155 572 0.00% Shares
Steward Partners Investment Advisory, LLC $10,476 493 0.00% Shares
DEUTSCHE BANK AG\ $7,884 371 0.00% Shares
LORD, ABBETT & CO. LLC $4,472 210,442 0.00% Shares
COMERICA BANK $4,091 150 0.00% Shares
FIFTH THIRD BANCORP $3,188 150 0.00% Shares
Caitong International Asset Management Co., Ltd $2,401 113 0.00% Shares
GROUP ONE TRADING LLC $2,210 104 0.00% Shares
Sterling Capital Management LLC $1,445 68 0.00% Shares
MORGAN STANLEY $829 39 0.00% Shares
ASSETMARK, INC $723 34 0.00% Shares
Quarry LP $574 27 0.00% Shares
PRICE T ROWE ASSOCIATES INC /MD/ $338 15,900 0.00% Shares
JPMORGAN CHASE & CO $256 12 0.00% Shares
SBI Securities Co., Ltd. $255 12 0.00% Shares
REAP Financial Group, LLC $64 3 0.00% Shares
Allworth Financial LP $22 1 0.00% Shares

Company insiders 26 insiders · 9 officers · 19 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Paul A. Wagner CEO, Secretary and Chair of the Board July 1, 2026 M 85,482 0 0 $0
Martin J Duvall Chief Executive Officer Oct. 4, 2019 A 13,605 0 0 $0
Antony A Riley CHIEF FINANCIAL OFFICER July 1, 2026 M 42,600 1 0 $254,874
Mark G Foletta EVP & Chief Financial Officer Oct. 4, 2019 A 15,042 0 0 $0
Hubert C Chen President and Chief Scientific Officer Jan. 1, 2024 M 93,405 0 0 $0
Harry E Gruber President, Science&Innovation Feb. 26, 2020 A 23,685 0 0 $0
Fairooz Kabbinavar SVP Clinical Development Oct. 4, 2019 A 0 0 $0
Douglas Jolly EVP, Research & Pharm Devel Oct. 4, 2019 A 393,478 0 0 $0
Asha Das SVP & Chief Medical Officer March 1, 2018 A 5,000 0 0 $0
Shivpreet Singh Kapoor Director May 29, 2026 A 0 0 $0
Scott C. Brun Director May 29, 2026 A 0 0 $0
Steven Kornfeld Director May 29, 2026 A 99,009 0 0 $0
Stephen K Doberstein Director May 29, 2026 A 0 0 $0
Richard G Vincent Director May 29, 2026 A 0 0 $0
David W Gryska Director May 29, 2026 A 148,514 0 0 $0
Lawrence Eichenfield Director Sept. 19, 2023 A 0 0 $0
Donald Allen Williams Director Sept. 19, 2023 A 59,405 0 0 $0
Barbara K Finck Director Sept. 19, 2023 A 0 0 $0
Patricia S Walker Director June 1, 2022 A 0 0 $0
Thomas E Darcy Director Jan. 13, 2021 M 2,358 0 0 $0
Lori Anne Kunkel Director Oct. 4, 2019 A 0 0 $0
David Ross Parkinson Director Oct. 4, 2019 A 0 0 $0
Faheem Hasnain Director Oct. 4, 2019 A 245,857 0 0 $0
Franklin M Berger Director Oct. 4, 2019 A 25,335 0 0 $0
SCHIMMEL PAUL Director Oct. 4, 2019 A 13,623 0 0 $0
Steven Michael Oliveira 10% owner April 14, 2020 P 2,873,450 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 6 positions

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Camac Partners, LLC, Camac Capital, LLC, Camac Fund, LP, Eric Shahinian, ATG Fund II LLC, ATG Capital Management, LLC, Gabriel Gliksberg, Michael G. Hacke, McIntyre Partnerships, LP, McIntyre Capital GP, LLC, McIntyre Capital Management, LP, McIntyre Capital Management GP, LLC, Chris McIntyre ×11 filings June 17, 2024 Initial filing SEC
BML Investment Partners, L.P. ×6 filings Jan. 11, 2024 Initial filing SEC
Funicular Funds, LP, Jacob Ma-Weaver ×6 filings Jan. 9, 2024 Initial filing SEC
Paul A. Wagner, Ph.D. (2) ×2 filings Aug. 15, 2023 Initial filing SEC
ATG Fund II LLC, ATG Capital Management, LLC, Gabriel Gliksberg ×2 filings Aug. 10, 2023 Initial filing SEC
Paul A. Wagner, Ph.D. June 25, 2020 Initial filing SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 13 ETFs

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
IWC · iShares Trust 0.34% 65,797 SH Aug. 8, 2026 Daily
SBIO · ALPS ETF Trust 0.15% 12,912 NS May 31, 2026 N-PORT
IWO · iShares Trust 0.09% 177,467 SH Aug. 8, 2026 Daily
OMFS · Invesco Exchange-Traded Self-Indexe… 0.05% 1,757 SH Aug. 8, 2026 Daily
IWM · iShares Trust 0.05% 485,030 SH Aug. 8, 2026 Daily
VTWG · VANGUARD SCOTTSDALE FUNDS 0.02% 20,646 SH Aug. 8, 2026 Daily
VTWO · VANGUARD SCOTTSDALE FUNDS 0.01% 111,500 SH Aug. 8, 2026 Daily
ITOT · iShares Trust 0.00% 30,190 SH Aug. 8, 2026 Daily
IWV · iShares Trust 0.00% 5,159 SH Aug. 8, 2026 Daily
AVSC · AMERICAN CENTURY ETF TRUST 0.00% 1,062 NS May 31, 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0.00% 217,359 SH Aug. 8, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.00% 622,927 SH Aug. 8, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 1,625 SH Aug. 8, 2026 Daily